What can we expect from the UK life science sector as it continues to mature?

Life science remains a hot topic for many within real estate, with a number of new entrants looking to break into the UK market as the sector continues to mature. However, with the current funding landscape impacted by wider macro-economics, and more hesitancy from those looking to invest, it is important to stress that the fundamentals remain strong. 

Join Guy Ruddle and guests, Tom Mellows, Savills head of UK science, Olivia Drew, director and portfolio manager of UK life sciences at UBS and Freddie Dear, investment manager at Monograph Capital and head of corporate development at Ascend Gene & Cell Therapies, as they discuss what’s needed to meet the sector’s growing requirements.